Dactinomycin and Bisacodyl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dactinomycin (dactinomycin) and Bisacodyl (bisacodyl). Common drug interactions include anaemia among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Dactinomycin and Bisacodyl. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Dactinomycin?

Dactinomycin has active ingredients of dactinomycin. eHealthMe is studying from 2,577 Dactinomycin users. Check the latest studies of Dactinomycin.

What is Bisacodyl?

Bisacodyl has active ingredients of bisacodyl. It is often used in constipation. eHealthMe is studying from 18,852 Bisacodyl users. Check the latest studies of Bisacodyl.



On Jul, 19, 2026

11 people who take Dactinomycin and Bisacodyl together, and have interactions are studied.

Dactinomycin and Bisacodyl drug interactions.

What are the common drug interactions of Dactinomycin and Bisacodyl, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Maternal exposure during pregnancy (use of substance during pregnancy)
  3. Premature baby

male:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Headache (pain in head)
  3. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  4. Haemoglobin decreased
  5. Multi-organ disorder (multiple organ disease)
  6. Platelet count decreased
  7. White blood cell count decreased
  8. Chills (felling of cold)
  9. Pyrexia (fever)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

What are the common drug interactions of Dactinomycin and Bisacodyl, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Multi-organ disorder (multiple organ disease)
  2. Platelet count decreased
  3. White blood cell count decreased
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Headache (pain in head)
  6. Chills (felling of cold)
  7. Pyrexia (fever)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  10. Haemoglobin decreased

20-29:

n/a

30-39:

  1. Anaemia (lack of blood)
  2. Maternal exposure during pregnancy (use of substance during pregnancy)
  3. Premature baby

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Wilms Tumor (cancer of the kidneys that typically occurs in children): 5 people, 45.45%
  2. Laxative Supportive Care: 5 people, 45.45%
  3. Neoplasm Malignant (cancer tumour): 4 people, 36.36%
  4. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Dactinomycin and Bisacodyl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dactinomycin and Bisacodyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dactinomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bisacodyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dactinomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bisacodyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dactinomycin and bisacodyl (the active ingredients of Dactinomycin and Bisacodyl, respectively), and Dactinomycin and Bisacodyl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: